Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,285 public trials 413 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Active, Not Recruiting

BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer

NCT07511517

Conditions
Carcinoma, Carcinoma, Transitional Cell, Bladder, Female Urogenital Diseases, +15 more
Locations
  • Haukeland University Hospital Bergen, Norway
  • Akershus University Hospital (Ahus) Lørenskog, Norway
  • Oslo University Hospital - Aker Oslo, Norway
  • University Hospital of North Norway (UNN) Tromsø, Norway
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

NCT05858736

Conditions
Adenocarcinoma, Adnexal Diseases, Anal Cancer, +85 more
Locations
  • St. Vincent's Private Hospital Darlinghurst, New South Wales, Australia
  • Mater Misericordiae Ltd. Brisbane, Queensland, Australia
  • Tasman Oncology Research Southport, Queensland, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View Trial Details
Active, Not Recruiting

Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

NCT04794699

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lung Diseases, +14 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Orlando Health Cancer Institute Orlando, Florida, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

Determinants of Bladder Cancer Recurrence Study (The DETER Study)

NCT02400944

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder

NCT02845323

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • UCLA Institute of Urologic Oncology Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer

NCT02138734

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Alaska Clinical Research Center Anchorage, Alaska, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • Center for Neurosciences Tucson, Arizona, United States
View all 108 locations
View Trial Details

Related conditions